Observational studyBMJ open2022

Symptom Improvement of ulceRative colitis after an Induction dose of UStekinumab in Japanese clinical practice (SIRIUS), measured using patient-reported outcomes: a prospective observational study.

Katsuyoshi Matsuoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.